Oklahoma Attorney General's Office
Recent News About Oklahoma Attorney General's Office View More
-
J&J's lawyers note opioids researcher being paid hundreds of thousands for testimony in Oklahoma trial
NORMAN, Okla. (Legal Newsline) – Attorneys defending Johnson & Johnson on Monday fended off accusations their client caused an addiction crisis and shifted attention onto Purdue Pharma, while also noting a plaintiffs expert is being paid upward of $500,000 for his testimony. -
Oklahoma's governor is worried AG Hunter won't turn $85M opioid settlement over to treasury
NORMAN, Okla. (Legal Newsline) – Oklahoma Gov. Kevin Stitt and two high-ranking lawmakers fear that funds from a recent opioid settlement won't head their way and are asking to intervene, claiming Attorney General Mike Hunter's recent $85 million agreement with Teva Pharmaceutical might violate a new state law. -
Witness list offers a preview of arguments to come in Oklahoma's big opioid trial
NORMAN, Okla. (Legal Newsline) – Not all named witnesses will be called to testify in the two-month-long trial that is beginning its fourth week in Cleveland County Court - a trial that pits the State of Oklahoma against Johnson & Johnson over the abatement of what Oklahoma calls a man-made opioid crisis - but 10 of the more than 160 listed overlap the sides. -
Attorneys for J&J spar with opioids researcher over warning labels during Oklahoma trial
NORMAN, Okla. (Legal Newsline) – Attorneys for Johnson & Johnson on Friday during questioning of a researcher called as a witness by the State attempted to establish that the company’s production of opioid drugs was a government-regulated process with detailed warnings of possible addiction provided. -
J&J finally gets chance to question opioids researcher during Oklahoma trial, fights 'kingpin' remark
NORMAN , Okla. (Legal Newsline) – On his third day of testimony, an opioids researcher was cross-examined by attorneys for Johnson & Johnson as the company defends itself from allegations that it is to blame for the nation's addiction crisis. -
'It keeps changing': Oklahoma's opioid strategy is a 700-year-old English law that used to regulate wandering sheep
NORMAN, Okla. (Legal Newsline) - The opioid trial now underway in a county courthouse in Oklahoma offers the first look at a legal strategy that could result in tens of billions of dollars in liability against the manufacturers and distributors of addictive narcotic painkillers in similar lawsuits nationwide. -
Oklahoma witness in opioid trial says drug users not to blame for addiction crisis
NORMAN, Okla. (Legal Newsline) – During a second day of testimony, an opioid researcher questioned by private attorneys hired by the State of Oklahoma said opioid sellers like Johnson & Johnson sought to shift blame for a prescription drug epidemic onto those not responsible. -
Opioids researcher takes stand to criticize J&J in Oklahoma trial
NORMAN, Okla. (Legal Newsline) – An opioids researcher on Tuesday compared doctors over-prescribing opioids to the breaking of a figurative dam that flooded Oklahoma - and the country - during testimony in an important trial taking place in the state. -
Marketing of J&J's opioids discussed at Oklahoma's big trial
NORMAN, Okla. (Legal Newsline) – A marketing specialist told attorneys for the State of Oklahoma on Monday that the rise in the sales of opioid drugs could be tied to a similar rise over the same period from 1996 to 2017 to deaths from overdose. -
Okla. AG's lawyers offer testimony of addict in big opioid trial, but witness said he never used J&J's products
NORMAN, Okla. (Legal Newsline) – A resident of this small Oklahoma town recounted the hell of his addiction to opioid drugs that began with a legal prescription and then spiraled out of control, testifying in a lawsuit accusing Johnson & Johnson of causing a drug epidemic. -
Oklahoma's hired guns continue to portray Johnson & Johnson as evil to judge in opioid trial
NORMAN, Okla. (Legal Newsline) – On Wednesday, private attorneys hired by the State of Oklahoma on a contingency fee accused Janssen Pharmaceuticals, the drug arm of Johnson & Johnson, of ignoring the warning signs of a nationwide addiction crisis in order to maximize profit. -
In high-profile opioid trial, Johnson & Johnson reminds that its addiction warnings were approved by the FDA
NORMAN, Okla. (Legal Newsline) – Defense attorneys for Johnson & Johnson took over the questioning of Kimberly Deem-Eshleman, southeast regional business director for Janssen Pharmaceuticals and the marketer of its opioid drug Nucynta, attempting to establish that drug labels had provided plenty of warnings about possible addiction. -
Janssen exec questioned for third day by Oklahoma's hired guns in big opioid trial
NORMAN, Okla. (Legal Newsline) – In the closely watched opioid trial taking place in Oklahoma, private attorneys representing the State on Monday sought to portray Johnson & Johnson and its drug subsidiary Janssen Pharmaceuticals as marketing drugs like Nucynta for profit in order to feed an opioid epidemic they ignored. -
Father recounts loss of son in Oklahoma Johnson & Johnson opioid trial
NORMAN, Okla. (Legal Newsline) – Fighting back tears, a father who lost his son to an opioid overdose recounted the nightmare during testimony in a trial alleging that Johnson & Johnson flooded the state with addictive drugs for profit. -
Oklahoma's AG is twisting the law to suit his high-profile opioid case, Johnson & Johnson says
NORMAN, Okla. (Legal Newsline) – Oklahoma’s attorney general and the private lawyers he hired – who are earning millions from a lawsuit over the nation’s addiction crisis – are using a mangled interpretation of state law as they seek to generate headlines, one of the sued companies says. -
Okla. AG's $260M opioid settlement could foreshadow future settlements and fights over who gets the money
OKLAHOMA CITY (Legal Newsline) - A week after Oklahoma Attorney General Mike Hunter announced a $270 million settlement with Purdue Pharma, lawmakers are questioning why they weren’t consulted on the deal or how to distribute the money. -
Okla. opioid settlement: Most to OSU, lawyers, and small percentage to cities and counties
OKLAHOMA CITY (Legal Newsline) – A small portion of the $270 million settlement reached by Purdue Pharma and Oklahoma Attorney General Mike Hunter “directly” addresses the opioid crisis around the state, while the bulk goes to lawyers and a treatment center at Oklahoma State University. -
Oklahoma attorney general's motions regarding federal tax cut savings receives approval
OKLAHOMA CITY — Oklahoma's Corporate Commission has voted to approve the motions filed by the state's attorney general that request Oklahoma Natural Gas (ONG) return money saved from the 2017 federal tax cuts to utility customers. -
Oklahoma Military Planning Commission, wind farm developer reach agreement
OKLAHOMA CITY — Construction of an Oklahoma wind farm has been put on hold stemming from a claim by the Oklahoma Strategic Military Planning Commission (OSMPC) that the construction violates an amendment to the Wind Energy Development Act, which took affect earlier this year. -
Oklahoma attorney general announces $64 million rate reduction settlement with energy supplier
OKLAHOMA CITY — Oklahoma Gas and Electric (OG&E) Energy Corp., has agreed to a $64 million rate reduction settlement which Oklahoma Attorney General Mike Hunter is touting as an historic event that will result in lower utility bills for OG&E customers starting this summer.